1. https://spid.center/articles/419.
![](https://resizer.mail.ru/p/edfe002e-59c5-53d5-b232-765bc0265357/AQAFcsgzZE_87wlAXO5MQtFBn-LMQuZOCX2lpJuaIeg7dq-Zf5y0_wDdFnG4xhvdFRFRsGFn-RrfXAOlpLJvsRZUyzI.jpg)
![](https://resizer.mail.ru/p/18b739b2-3663-5159-800b-54b54516a548/AQAFPo0WtscPShngwggpScb-Z4xlBvlHT4NJiDBaHTwhehoj1vWgth_WM9rSt8gWSszsN9joWfbT3p0gXJRA-bqXKow.jpg)
![](https://resizer.mail.ru/p/20e8f269-389d-58d4-8b01-417f448d093b/AQAFzSFCcRuHU9vmTUS39nG3nMWEJlPnPAwIzdEeqPCNt6dK-B58DnYnJfmPUGI8iCthg3OSVJTNvnUO6SsxgEcwpl0.jpg)
![](https://resizer.mail.ru/p/45734c24-af43-50d1-b1ef-c61137d1d5fb/AQAFu5VklQST4WKItSAO4VcZC--ssooTgFWek1PeqLJ6lpoYFT_DSOp7mXNw9BToYA_l1xgfWFW1rrw-LlmcgPDHN4A.jpg)
![](https://resizer.mail.ru/p/ba7c1fa6-bb61-55d9-9c28-e2f78fa4ef0b/AQAFRzEz_RF168v5tL8aALcLQQ4Wu6EmojPaQVsOD9BKAdH2tqLqVO36H4sh48uW6hgmLGuW4JwN2zFxIDiUGPxM660.jpg)
![](https://resizer.mail.ru/p/dc5e6338-e9c3-56c0-8b08-82a7f3f12a4b/AQAFJ2Jmrfv4F_GlnFF-UjnVK3m4CFdG9Y-lF3v4YTr6YLlhsFGYqNwGKHGfu2NlVoTXxqzpbLq_I3Hx_9n2MPWQdD0.jpg)
![](https://resizer.mail.ru/p/1e7cd2bb-7c05-5cc3-b2f9-56cf4e5fb68a/AQAFTGc2_fz84UUQgdjnra8c_fFVYQIS4e_TG9GUd3Q89xZn7fHuxyXUXWiXSb3tppFt6qqeB8hP-Q2t9-sesFJLBF0.jpg)
![](https://resizer.mail.ru/p/1ea35086-535e-538d-82f6-d6362a3acb91/AQAFnGZM8KEaJI2D786Lftjxplv_NtO-YX32y871gIhd_hS4mmJ6knMoX9zAQKF-NFnNvxxGnkWEnqjVcvElXknT03Y.jpg)
![](https://resizer.mail.ru/p/e75bcc63-2656-581c-8ef6-0b752b8643d2/AQAFgRi5bn4GzFfqDSa8Z05kYRleoHR88dqt9gsqIzvaqB0pNWOlwIRB99pd7WRcRRkkVDHynrMQmtg8gaUPfnmSAQY.jpg)
2. Bauer H: The Case for the Loch Ness «Monster»: The Scientific Evidence. Journal of Scientific Exploration 2002, 16(2):225—46.
3. http://visual-science.com/ru/projects/hiv/illustrations.
4. Liu J et al: 3D visualization of HIV virions by cryoelectron tomography. Methods Enzymol 2010, 483:267-90.
5. Lopalco L: CCR5: From Natural Resistance to a New Anti-HIV Strategy. Viruses 2010, 2(2):574-600.
6. Hutter G et al: Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009, 360(7):692-8.
7. Allers K et al: Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 2011, 117(10):2791-9.
8. Dorr P et al: Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother 2005, 49(11):4721-32.
9. Holt N et al: Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 2010, 28(8):839-47.
10. Perez EE et al: Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 2008, 26(7):808-16.
11. Cornu TI et al: Editing CCR5: a novel approach to HIV gene therapy. Adv Exp Med Biol 2015, 848:117-30.
12. Kuwata T et al: Association of progressive CD4(+) T cell decline in SIV infection with the induction of autoreactive antibodies. PLoS Pathog 2009, 5(4):e1000372.
13. Juompan LY et al: Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates. AIDS Res Hum Retroviruses 2008, 24(4):573-86.
14. Gallo RC, Montagnier L: The discovery of HIV as the cause of AIDS. N Engl J Med 2003, 349(24):2283-5.
15. Ratner L et al: Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985, 313(6000):277-84.
16. https://www.ncbi.nlm.nih.gov/nuccore/AF033819.
17. Chou R et al: Screening for HIV: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2005, 143(1):55-73.
18. Davis KR, Weller SC: The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999, 31(6):272-9.
19. Giannou FK et al: Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res 2016, 16(4):489-99.
20. Ebina H et al: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.
19. Giannou FK et al: Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res 2016, 16(4):489-99.
20. Ebina H et al: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.
19. Giannou FK et al: Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res 2016, 16(4):489-99.
20. Ebina H et al: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.
19. Giannou FK et al: Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res 2016, 16(4):489-99.
20. Ebina H et al: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.